How to Run a 3-Touch Email Campaign That Engages European CRO Decision-Makers (2026)

Quick Answer: Origami includes a built-in email sequencer that lets you run multi-step campaigns to European CRO decision-makers without leaving the platform. You find verified contacts, refine the list, write (or have the AI generate) a 3-touch sequence, and send — all inside one dashboard. This guide walks through the exact campaign I’ve used to get replies from CRO leaders across Europe, with full email copy you can copy‑paste.

If you haven’t built your prospect list yet, start with our companion guide on how to build a list of and Engage European CRO Decision-Makers. For this post, I’m assuming you’ve already pulled a fresh list of decision-makers at European Contract Research Organisations (CROs) using Origami. Now let’s refine that list and launch a sequence that actually converts.

Step 1: Build the List in Origami (Recap)

Even if you already have your list, it’s worth revisiting the exact prompt to make sure the targeting is tight. Inside Origami, you describe your ideal customer in plain English. For European CRO decision-makers, the prompt I’d use today looks like this:

Decision-makers at European contract research organisations (CROs), with titles like Chief Revenue Officer, VP of Business Development, Head of Clinical Operations, Director of R&D, at companies with 50–500 employees, based in Europe.

Origami’s AI agent then searches the live web, chains data sources, and returns a clean prospect list. Each row comes with:

• Verified full name and email address
• Current job title and department
• Company name, size, location, and industry
• Technologies the company uses (if publicly visible)
• Phone numbers where available

You can run this even on the free plan (1,000 credits, no credit card required), which covers a small initial batch. For a larger campaign, paid plans start at $29/month. The key point: in 2026, you don’t need to bounce between a dozen tools to get a targeted list — it’s one prompt away.

Step 2: Refine and Qualify the List

A raw list still contains people who are a weak fit. Before you write a single email, spend 15 minutes segmenting and qualifying. In Origami, you can filter by country, company size, and role directly in the table view and then bulk‑remove contacts that don’t match.

Segments that matter for European CROs:

• Country clusters. Nordic, DACH, Benelux, and Mediterranean regions often have different regulatory pressures. Segmenting by geography lets you tailor language around local trial requirements later.
• Company size. CROs with 50–200 employees are the sweet spot — large enough to invest in process improvements, small enough that decisions don’t require a 12‑person committee.
• Functional role. Separate business‑development leaders (CRO, VP BD) from operational heads (Head of Clinical Ops, Director of R&D). The ops people feel the pain of trial inefficiencies daily; BD leaders care about win rates and margins. Your messaging will shift slightly depending on which group you’re emailing.
• Therapeutic area. If your product serves oncology or rare‑disease trials, look for CROs that publicly mention those indications. Origami surfaces tech‑stack data, which sometimes includes speciality signals.

What “qualified” looks like for this audience:

A strong lead is a senior operator (Head of Clinical Operations, Director of R&D, or even a Founder/CEO at a smaller CRO) at a mid‑sized European CRO that is actively running multi‑country trials. This person either owns vendor selection or directly influences it. They’re juggling data quality, patient recruitment timelines, and EMA compliance — and they’ll open an email that speaks to those headaches.

Remove contacts where the title is too junior, the company appears to be a micro‑agency with under 20 people, or the email domain doesn’t match the company name. Those rarely convert. A clean, qualified list of 200 beats a generic list of 2,000 every time.

Step 3: Create the Email Sequence

Origami gives you two ways to build your sequence:

1. Paste your own templates. Write a 3‑touch sequence (Day 1, Day 3, Day 7 — whatever cadence you prefer), drop the templates into Origami’s sequencer, set the delay between touches, and hit “Launch.” The platform will personalise each message with contact fields like {first_name} and {company}.
2. Let the agent write it. Ask Origami’s AI to generate a personalised 3‑day email sequence for all your leads automatically. The agent writes each message based on each lead’s profile data — title, company, industry — so every message reads like a one‑to‑one email, not a mail merge.

Whichever route you choose, the copy must be tight. Decision-makers at CROs are drowning in pitches. Below is the full 3‑touch sequence I’ve refined over dozens of campaigns targeting this audience. Copy it, tweak the value props to match your product, and paste it straight into Origami.

Sequence: 3 Touches Over 7 Days

Touch 1 — Day 1 (Initial Cold Email)

Subject: Streamlining {company}’s trial data? Preview text: One question about your European trials…

Hi {first_name},

I see you’re overseeing clinical ops at {company}. Most CRO leaders we speak with tell us the same thing: keeping trial data audit‑ready across EMA, MHRA, and ANSM is a constant struggle. We built [product] to automate data cleaning and flag compliance gaps before auditors do.

Would you be open to a 10‑minute call to see if it fits?

Best, {sender}

Why this works: It names a specific pain (multi‑regulator compliance) that’s unique to European CROs. No generic “I saw your LinkedIn”.

---

Touch 2 — Day 3 (Different Angle)

Subject: Filling EU cohorts faster? Preview text: A thought on patient recruitment at {company}…

Hi {first_name},

Quick follow‑up — you may also be wrestling with patient recruitment timelines. It’s the #1 bottleneck we hear from CRO teams running pan‑European studies. We’ve helped sponsors and CROs shorten enrolment periods using intelligent site selection and digital engagement tools, without adding headcount.

Curious if this could help your current trials?

Cheers, {sender}

Why this works: The second touch brings a fresh angle, so you’re not just repeating the first message. Patient recruitment is a universal CRO stressor, making it high‑relevance even for someone who ignored the data‑management hook.

---

Touch 3 — Day 7 (Breakup)

Subject: Closing the loop, {first_name} Preview text: Final note — in case timing was off.

Hi {first_name},

I haven’t heard back, so I’ll leave it here. If your team starts exploring ways to improve trial efficiency or data integrity later this year, feel free to reach out.

All the best, {sender}

Why this works: The breakup email is under‑rated. A low‑pressure final message earns surprising replies (often “Not now, but try me in Q3”). It also keeps your domain reputation clean, because you stop sending to unengaged addresses after this step.

All three messages sit between 50 and 100 words. Short, human, no fluff. The key is that every sentence ties to something a European CRO decision-maker actually cares about — not a feature list.

Step 4: Send the Sequence Directly from Origami

Here’s where the platform really earns its place. Once your sequence is ready, you launch it directly from Origami — no exporting CSVs, no syncing with an external mail tool, no Zapier tangle.

Inside the sequencer you configure:

• Delay between touches: Day 1 → wait 2 days → Day 3 → wait 4 days → Day 7 (or your preferred cadence)
• Sending window: Set a timezone‑aware schedule so emails land during working hours across European time zones
• Tracking: Opens, clicks, and replies appear in the same dashboard where you built your list

What makes the built‑in sequencer a real advantage:

• Prospect context. While reviewing a contact’s activity, you still see their enriched profile — title, company, tech stack — so you remember exactly why you reached out. No flipping tabs.
• Automatic un‑enrollment. If someone replies, they exit the sequence immediately. You’ll never accidentally send a breakup email after a booked meeting. This is something standalone sequencers often miss, and it saves trust with your prospects.
• All‑in‑one workflow. Find, enrich, sequence, send, track — one platform. The Origami sequencer is included on all paid plans; you only pay for the credits used to enrich leads. Sending itself is free.

Performance benchmarks and iteration

For a well‑segmented list of 200–400 European CRO decision-makers, you can realistically expect:

• Open rates: 45–65% (CRO execs are email‑heavy but selective)
• Reply rates (positive): 2–5% on the first cold batch, often climbing to 5–8% after you iterate
• Meeting bookings: 1–3% conversion to a scheduled call

If your open rate is below 40%, the problem is usually subject lines or deliverability — tweak headlines and check domain warm‑up. If opens are decent but replies are under 2%, your messaging isn’t resonating (or you’re targeting the wrong roles). Swap in a different problem angle, or refine the list to exclude people who don’t directly own the pain point you’re solving. The sequence above has been iterated across multiple campaigns; still, every product and territory is different, so treat it as a starting point, not dogma.

---

FAQ

What subject lines work best for CRO decision-makers?

Specific, problem‑centric subject lines outperform clever ones every time. Hint at a familiar pain — Streamlining {company}’s trial data? or Filling EU cohorts faster? work because they signal immediate relevance. Avoid broad statements (“Improve efficiency”) and never use “Re:” or “Fwd:” — it erodes trust fast.

How do I keep my emails out of spam when targeting European organisations?

Use a properly warmed‑up custom domain, keep volume per day moderate (especially for new domains), and avoid image‑heavy templates. Origami handles authenticated sending and includes a short warm‑up window for new inboxes. Equally important: send only to verified emails, which Origami enriches — bounced emails will tank your reputation.

Can I really personalise at scale without spending hours?

Yes. The sequence copy I’ve shared uses dynamic fields like {first_name} and {company}, but Origami’s AI agent can go deeper. If you choose the agent‑written option, it references the prospect’s title, company size, and even industry when crafting each message, so a Head of Clinical Ops at a 100‑person oncology CRO gets a different opening line than a VP of BD at a 400‑person full‑service CRO. It’s not generic; it’s profile‑aware.

How many follow‑ups should I send?

A 3‑touch sequence (initial + 2 follow‑ups) is the sweet spot for this audience. More than three risks annoyance; fewer often leaves replies on the table. Just ensure each follow‑up brings a new angle, not another nudge.

What if a prospect replies in the middle of the sequence?

With Origami’s built‑in sequencer, any reply instantly un‑enrolls that contact from the remaining touches. You’ll see the reply in your activity feed and can respond manually from the same dashboard. No bot‑like “Oops, here’s my Day 3 email anyway” moments.

---

You’ve now got the exact playbook — from list refinement to the final breakup message — for reaching European CRO decision-makers with email in 2026. Pair this with a well‑built list from Origami, and you’ll spend more time on real conversations and less time wrestling with tools.